Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis

Bin Tang1 Department of Respiratory Medicine, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, No. 92 Aiguo Road, Nanchang, 330006, Jiangxi, China, [email protected]

Jun Wang1 Department of Respiratory Medicine, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, No. 92 Aiguo Road, Nanchang, 330006, Jiangxi, China, [email protected]

Lin-lin Luo1 Department of Respiratory Medicine, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, No. 92 Aiguo Road, Nanchang, 330006, Jiangxi, China, [email protected]

Qiu-gen Li1 Department of Respiratory Medicine, Jiangxi Provincial People’s Hospital Affiliated to Nanchang University, No. 92 Aiguo Road, Nanchang, 330006, Jiangxi, China, [email protected]Correspondence[email protected]

Dan Huang2 Department of Anesthesiology, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi, China, [email protected]Correspondence[email protected]

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis

Citations (3)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date